NHS Newborn Blood Spot Screening Programme

More information

The UK Newborn Screening Programme Centre has responsibility for developing, implementing and maintaining a high quality, uniform screening programme for all newborn babies and their parents.

The National Screening Committee recommend that all babies in the UK are offered screening for phenylketonuria (PKU), congenital hypothyroidism (CHT), sickle cell disease (SCD), cystic fibrosis (CF) and medium-chain acyl-CoA dehydrogenase deficiency (MCADD). Some UK-wide programme variation exists, which is explained further on the UK programme comparison chart.

Further resources

Access the UK Newborn Screening Programme Centre website at newbornbloodspot.screening.nhs.uk or use these direct links:

• Public information
• Professional information
• Press office
• Contact details

Map of Medicine Care Pathway (on NHS Choices)

• Newborn Blood Spot Screening

UK NSC Policy Statements

• Phenylketonuria (PKU)
• Congenital hypothyroidism (CHT)
• Sickle cell disease (SCD)
• Cystic fibrosis (CF)
• Medium chain acyl CoA dehydrogenase deficiency (MCADD)